Rituxan articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/09/14 17:16
2014/09/14 17:16
6h
At least 14 expensive biotechnology medicines that have never before faced generic rivals in the U.S. are being targeted by drugmakers who want to sell imitations at cheaper prices, according to...
2014/09/14 17:16
2014/09/14 17:16
Latest videos
2014/08/26 21:35
2014/08/26 21:35
19d
An oncologist who has begun treating patients in Great Bend has come under scrutiny, triggered by a complaint to the Kansas Board of Healing Arts from a Reno County patient, according to a one-year...
2014/08/25 16:17
2014/08/25 16:17
20d
New Drugs to Boost Graft-Versus-Host Disease Treatment Market by 2018. The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at...
2014/08/25 12:22
2014/08/25 12:22
20d
Before this deal, there was nothing extraordinary about Roche's respiratory business. Roche has thrived mainly on its strength in cancer treatments. While the company's oncology position remains...
2014/08/18 17:44
2014/08/18 17:44
27d
A message to biotech start-ups, scientist-entrepreneurs and life sciences organizations banking on your exciting protein-based drug-discovery programs and technologies: When it comes to the timing of...
2014/08/18 15:31
2014/08/18 15:31
27d
LOS ANGELES (Reuters) - Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with...
2014/09/14 17:16
2014/09/14 17:16
Latest from Twitter